Restarting Wegovy after stopping: what the evidence says

What happens to your body when Wegovy is stopped

Semaglutide has a half-life of roughly a week, which means it clears from your system gradually over four to five weeks after your last dose. During that window (and well beyond it) the appetite-suppressing and gastric-slowing effects wind down. Hunger typically returns to pre-treatment levels, and without the hormonal signal that kept appetite in check, many people find weight returns relatively quickly.

The STEP 1 trial follow-up data, published in the New England Journal of Medicine, showed that participants who stopped semaglutide after 68 weeks had regained two-thirds of their lost weight within a year. This isn't a failure of willpower; it reflects how the biology of weight regulation works. The NHS semaglutide medicines page notes that ongoing treatment is generally needed to maintain results, which is one reason restarting is sometimes the right decision.

If you're thinking about what life looks like once you stop, our page on what happens after stopping Wegovy covers the physiology in more depth.

Why the reason you stopped changes the restart plan

A planned pause (say, because of surgery, pregnancy, or a deliberate structured break) is clinically very different from stopping because of intolerable side effects or a concern about a specific health change. Prescribers treat these situations differently for good reason.

If you stopped because of nausea, vomiting or other gastrointestinal effects, restarting at your previous dose would very likely reproduce those symptoms. The practical approach is to begin again from a lower dose and move through the titration steps more slowly, letting your body readjust. Think of it less as going back in time and more as starting a new course, with the benefit of knowing what to expect.

If you stopped because of a suspected serious reaction, that concern needs full clinical review before any restart is considered. And if you paused during pregnancy or while breastfeeding, guidelines are clear: semaglutide is not recommended in those circumstances, and a prescriber will assess your current situation before any new prescription. For more on the specifics of a brief stop, our guidance on stopping semaglutide after one week explains the short-term picture.

How a restart is typically structured

There is no single universal protocol for restarting Wegovy, but clinical practice in the UK tends to follow a consistent logic. If you have been off the medicine for more than a few weeks, most prescribers will recommend retitrating from 0.25 mg rather than rejoining at the dose you left. This protects against a spike in gastrointestinal side effects and gives the body time to re-establish tolerance.

The routine itself matters too. Patients who have been through the titration once often find the early doses more manageable the second time around, partly because they know what to anticipate. Keeping the pen in the same place (the fridge door, for example, alongside other weekly reminders) helps rebuild the once-weekly habit. Dose increases are still paced roughly every four weeks, and a prescriber decides when moving up is appropriate based on how you're tolerating each level.

Our detailed guide to stopping and restarting semaglutide covers the practical steps in full. For broader context on Wegovy as a treatment, the Wegovy overview page sets out what the medicine is licensed for in the UK and how the titration schedule is designed.

Making the decision: is restarting right for you?

Restarting isn't automatically the answer. The decision depends on your current BMI, any health changes since you stopped, what other medicines you're now taking, and what your goals are. Some people do better exploring whether a different treatment might be more suitable at this point — for example, if they found semaglutide's side-effect profile difficult, tirzepatide's dual mechanism works differently and may suit them better. You can read about semaglutide's mechanism and evidence to understand what distinguishes it from other options.

Cost is also a real factor for many people. If the expense of maintaining a private prescription prompted the original stop, it's worth understanding exactly what's included in any provider's pricing before restarting. Our page on Wegovy pricing in the UK gives an honest account of what the market looks like. The question of whether to restart, and when, is ultimately a clinical one. A prescriber who has the full picture (current weight, health status, the original reason for stopping) is the right person to answer it for your situation specifically.

If you'd like a prescriber to review your history and discuss whether restarting makes sense, you can check your eligibility with our clinical team.